{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T17:26:50Z","timestamp":1786210010049,"version":"build-2736575974"},"reference-count":31,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.3892\/mmr.2017.7486","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T09:28:52Z","timestamp":1505294932000},"page":"7131-7137","source":"Crossref","is-referenced-by-count":4,"title":["Aberrantly expressed transcription factors C\/EBP and SOX4 have positive effects in the development of chronic myeloid leukemia"],"prefix":"10.3892","volume":"16","author":[{"given":"Fei","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuena","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,9,13]]},"reference":[{"key":"key20180108003644_b1-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"key20180108003644_b2-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"N Engl J Med"},{"key":"key20180108003644_b3-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood-2010-08-301341","article-title":"Three decades of transplantation for chronic myeloid leukemia: What have we learned?","volume":"117","author":"Pavlu","year":"2011","journal-title":"Blood"},{"key":"key20180108003644_b4-mmr-16-05-7131","volume-title":"SEER Cancer Statistics Review, 1975\u20132009 (Vintage 2009 Populations)","author":"Howlader","year":"2012"},{"key":"key20180108003644_b5-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1182\/blood-2011-08-375535","article-title":"Poor response to second-line kinase inhibitors in chronic myeloid leukemia patients with multiple low-level mutations, irrespective of their resistance profile","volume":"119","author":"Parker","year":"2012","journal-title":"Blood"},{"key":"key20180108003644_b6-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(13)62120-0","article-title":"Chronic myeloid leukaemia","volume":"385","author":"Apperley","year":"2015","journal-title":"Lancet"},{"key":"key20180108003644_b7-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12185-015-1764-6","article-title":"C\/EBP\u03b1 in normal and malignant myelopoiesis","volume":"101","author":"Friedman","year":"2015","journal-title":"Int J Hematol"},{"key":"key20180108003644_b8-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"698.e1","DOI":"10.1016\/j.ccr.2012.10.017","article-title":"SnapShot: Acute myeloid leukemia","volume":"22","author":"Zeisig","year":"2012","journal-title":"Cancer Cell"},{"key":"key20180108003644_b9-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ncomms1008","article-title":"Organogenesis relies on SoxC transcription factors for the survival of neural and mesenchymal progenitors","volume":"1","author":"Bhattaram","year":"2010","journal-title":"Nat Commun"},{"key":"key20180108003644_b10-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.3892\/or.2015.3848","article-title":"Regulation of the C\/EBP\u03b1 signaling pathway in acute myeloid leukemia (Review)","volume":"33","author":"Song","year":"2015","journal-title":"Oncol Rep"},{"key":"key20180108003644_b11-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ccr.2013.09.018","article-title":"Sox4 is a key oncogenic target in C\/EBP\u03b1 mutant acute myeloid leukemia","volume":"24","author":"Zhang","year":"2013","journal-title":"Cancer Cell"},{"key":"key20180108003644_b12-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/ni.2362","article-title":"The transcription factor Sox4 is a downstream target of signaling by the cytokine TGF-\u03b2 and suppresses TH2 differentiation","volume":"13","author":"Kuwahara","year":"2012","journal-title":"Nat Immunol"},{"key":"key20180108003644_b13-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1182\/blood-2011-04-351528","article-title":"Sox4 cooperates with PU.1 haploinsufficiency in murine myeloid leukemia","volume":"118","author":"Aue","year":"2011","journal-title":"Blood"},{"key":"key20180108003644_b14-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1182\/blood-2011-05-357418","article-title":"Sox4 cooperates with CREB in myeloid transformation","volume":"120","author":"Sandoval","year":"2012","journal-title":"Blood"},{"key":"key20180108003644_b15-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1038\/onc.2012.506","article-title":"The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: Friend or foe?","volume":"32","author":"Vervoort","year":"2013","journal-title":"Oncogene"},{"key":"key20180108003644_b16-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1007\/s00018-012-1187-y","article-title":"Pleiotropic function of SRY-related HMG box transcription factor 4 in regulation of tumorigenesis","volume":"70","author":"Jafarnejad","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"key20180108003644_b17-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2012-05-428938","article-title":"SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia","volume":"121","author":"Ramezani-Rad","year":"2013","journal-title":"Blood"},{"key":"key20180108003644_b18-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180108003644_b19-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.scr.2015.10.015","article-title":"Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells","volume":"15","author":"Suknuntha","year":"2015","journal-title":"Stem Cell Res"},{"key":"key20180108003644_b20-mmr-16-05-7131","first-page":"42","article-title":"Tyrosine kinase inhibitors for the treatment of chronic-phase chronic myeloid leukemia: Long-term patient care and management","volume":"7","author":"Bauer","year":"2016","journal-title":"J Adv Pract Oncol"},{"key":"key20180108003644_b21-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1084\/jem.20050067","article-title":"Loss of C\/EBP\u03b1 cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage","volume":"202","author":"Porse","year":"2005","journal-title":"J Exp Med"},{"key":"key20180108003644_b22-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.immuni.2004.11.006","article-title":"Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C\/EBP alpha","volume":"21","author":"Zhang","year":"2004","journal-title":"Immunity"},{"key":"key20180108003644_b23-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1158\/0008-5472.CAN-12-0803","article-title":"Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia","volume":"72","author":"Baer","year":"2012","journal-title":"Cancer Res"},{"key":"key20180108003644_b24-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1046\/j.1365-2141.2002.03952.x","article-title":"Infrequent hypermethylation of CEBPA promotor in acute myeloid leukaemia","volume":"119","author":"Chim","year":"2002","journal-title":"Br J Haematol"},{"key":"key20180108003644_b25-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1179\/1607845413Y.0000000081","article-title":"Methylation status of CEBPA gene promoter in chronic myeloid leukemia","volume":"19","author":"Annamaneni","year":"2014","journal-title":"Hematology"},{"key":"key20180108003644_b26-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3324\/haematol.2012.074195","article-title":"The trithorax protein partner menin acts in tandem with EZH2 to suppress C\/EBP\u03b1 and differentiation in MLL-AF9 leukemia","volume":"98","author":"Thiel","year":"2013","journal-title":"Haematologica"},{"key":"key20180108003644_b27-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1182\/blood-2009-07-229450","article-title":"Differential ability of Tribbles family members to promote degradation of C\/EBPalpha and induce acute myelogenous leukemia","volume":"116","author":"Dedhia","year":"2010","journal-title":"Blood"},{"key":"key20180108003644_b28-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ccr.2013.10.016","article-title":"Sox4you: A new player in C\/EBP\u03b1 leukemia","volume":"24","author":"Fung","year":"2013","journal-title":"Cancer cell"},{"key":"key20180108003644_b29-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1182\/blood-2011-04-351528","article-title":"Sox4 cooperates with PU.1 haploinsufficiency in murine myeloid leukemia","volume":"118","author":"Aue","year":"2011","journal-title":"Blood"},{"key":"key20180108003644_b30-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1182\/blood-2004-12-4840","article-title":"Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis","volume":"106","author":"Du","year":"2005","journal-title":"Blood"},{"key":"key20180108003644_b31-mmr-16-05-7131","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1038\/leu.2014.153","article-title":"Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib","volume":"28","author":"Hanfstein","year":"2014","journal-title":"Leukemia"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T01:17:51Z","timestamp":1515374271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.7486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,9,13]]},"published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.3892\/mmr.2017.7486"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.7486","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}